Skip to content
healthcare.dev

RISPERDAL M-TAB

NDC 50458-355, risperidone, tablet, orally disintegrating, from Janssen Pharmaceuticals, Inc..

Product NDC
50458-355
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021444
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-355 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISPERIDONE4 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7e117c7e-02fc-4343-92a1-230061dfc5e0

Use it

Look up 50458-355 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-355 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-355. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.